News & Updates
Filter by Specialty:

HCPs, patients willing to trade off OCS benefits to avoid side effects
Both patients and healthcare professionals prefer treatment for asthma attacks that avoids the side effects of oral corticosteroids (OCS), and both are willing to trade off benefits, according to a study.
HCPs, patients willing to trade off OCS benefits to avoid side effects
12 Dec 2025
SARS-CoV-2 reinfection ups paediatric long COVID risk
Findings from the retrospective RECOVER-EHR* study show an increased risk of post-acute sequelae of SARS-CoV-2 infection (PASC), also known as long COVID, in children and adolescents after a SARS-CoV-2 reinfection.
SARS-CoV-2 reinfection ups paediatric long COVID risk
12 Dec 2025
CVD tops disease burden, death cause worldwide
The leading cause of disease burden and death across the globe is still cardiovascular disease (CVD), with low, low-middle, and middle sociodemographic index (SDI) regions carrying the heaviest burden, according to a study.
CVD tops disease burden, death cause worldwide
11 Dec 2025
ICONIC-LEAD affirms oral icotrokinra benefits in plaque psoriasis
In the phase III ICONIC-LEAD trial, selective blockade of the interleukin(IL)-23 receptor with the targeted oral peptide icotrokinra is associated with higher rates of skin clearance and symptom relief in adults and adolescents with moderate-to-severe plaque psoriasis.





